Earnings Feed
Sign Up
Home/Filings/4/0001179110-13-015570
4//SEC Filing

Astex Pharmaceuticals, Inc 4

Accession 0001179110-13-015570

CIK 0000919722operating
View on SEC.govCompany Profile

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 7:32 PM ET

Size

27.2 KB

Accession

0001179110-13-015570

Insider Transaction Report

Form 4
Period: 2013-10-11
Astex Pharmaceuticals, IncASTX
CASAMENTO CHARLES J
Director
Transactions
  • Disposition to Issuer

    Director Stock Option (Right to buy)

    2013-10-11−15,000→ 0 total
    Exercise: $7.79Exp: 2014-05-06→ Common Stock (15,000 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to buy)

    2013-10-11−833→ 0 total
    Exercise: $2.92From: 2011-06-16Exp: 2021-06-16→ Common Stock (833 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to buy)

    2013-10-11−35,000→ 0 total
    Exercise: $2.14Exp: 2020-06-10→ Common Stock (35,000 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to buy)

    2013-10-11−10,000→ 0 total
    Exercise: $5.88From: 2004-10-06Exp: 2014-10-06→ Common Stock (10,000 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to buy)

    2013-10-11−25,000→ 0 total
    Exercise: $2.92Exp: 2021-06-16→ Common Stock (25,000 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to buy)

    2013-10-11−20,000→ 0 total
    Exercise: $3.97Exp: 2016-06-09→ Common Stock (20,000 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to buy)

    2013-10-11−7,500→ 0 total
    Exercise: $3.26Exp: 2019-09-17→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to buy)

    2013-10-01−32,500→ 0 total
    Exercise: $4.60Exp: 2023-06-13→ Common Stock (32,500 underlying)
Footnotes (18)
  • [F1]The option provided for vesting as to 1/4th of the shares on May 6, 2004 and on each three month anniversary thereafter.
  • [F10]The option provided for vesting as to 1/4th of the shares on September 17, 2009 and on each three month anniversary thereafter.
  • [F11]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $39,300.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F12]The option provided for vesting as to 1/4th of the shares on June 10, 2010 and on each three month anniversary thereafter.
  • [F13]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $222,600.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F14]The option provided for vesting as to 1/4th of the shares on June 16, 2011 and on each three month anniversary thereafter.
  • [F15]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $139,500.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F16]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $4,648.14, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F17]The option originally provided for vesting as to 1/4th of the shares on June 13, 2013 and on each three month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
  • [F18]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $126,750.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F2]Pursuant to the Agreement and Plan of Merger, dated September 5, 2013, between the Issuer, Otsuka Pharmaceutical Co., Ltd., and Autumn Acquisition Corporation (the "Merger Agreement"), the option was cancelled in exchange for a cash payment of $10,650.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F3]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $26,200.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F4]The option provided for vesting as to 1/4th of the shares on May 12, 2005 and on each three month anniversary thereafter.
  • [F5]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $54,900.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F6]The option provided for vesting as to 1/4th of the shares on June 9, 2006 and on each three month anniversary thereafter.
  • [F7]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $90,600.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F8]The option provided for vesting as to 1/4th of the shares on June 14, 2007 and on each three month anniversary thereafter.
  • [F9]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $52,200.00, which represents the difference between $8.50 and the exercise price of the option per share.

Documents

1 file

Issuer

Astex Pharmaceuticals, Inc

CIK 0000919722

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000919722

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 7:32 PM ET
Size
27.2 KB
View on SEC.gov